Table 2.
Correlation of estrogen receptor beta (ERβ) expression with clinicopathological parameters
| Variable | n | ERβ expression | P value | |
|---|---|---|---|---|
| Total | 84 | 26 (31.0%) | ||
| Sex | female | 43 | 16 (37.2%) | 0.243 |
| male | 41 | 10 (24.4%) | ||
| Age | ≤60 years | 24 | 7 (29.2%) | 1.000 |
| > 60 years | 60 | 19 (31.7%) | ||
| T status | 1–2 | 11 | 3 (27.3%) | 1.000 |
| 3–4 | 73 | 23 (31.5%) | ||
| N status | 0 | 35 | 11 (31.4%) | 1.000 |
| 1 | 49 | 15 (30.6%) | ||
| Tumor grade | 1–2 | 30 | 7 (23.3%) | 0.328 |
| 3 | 54 | 19 (35.2%) | ||
| Residual tumora | R0 | 39 | 11 (28.2%) | 0.487 |
| R1 | 42 | 15 (35.7%) | ||
| Perioperative therapy | Surgery alone | 30 | 13 (43.3%) | 0.086 |
| Chemoradiation/Chemotherapy | 54 | 13 (24.1%) | ||
amissing information on resection status in three patients